Moderna
MRNA
745 hedge funds and large institutions have $11.5B invested in Moderna in 2024 Q4 according to their latest regulatory filings, with 145 funds opening new positions, 232 increasing their positions, 252 reducing their positions, and 170 closing their positions.
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
3.99% more ownership
Funds ownership: 68.01% → 72% (+4%)
8% less repeat investments, than reductions
Existing positions increased: 232 | Existing positions reduced: 252
5% less funds holding
Funds holding: 788 → 745 (-43)
15% less first-time investments, than exits
New positions opened: 145 | Existing positions closed: 170
20% less call options, than puts
Call options by funds: $929M | Put options by funds: $1.16B
34% less capital invested
Capital invested by funds: $17.4B → $11.5B (-$5.93B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$143M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$134M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$95.4M |
| 4 |
D.E. Shaw & Co
New York
|
+$72.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$61.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$171M |
| 2 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$127M |
| 3 |
JP Morgan Chase
New York
|
-$81.4M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$77.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$62.6M |
MRNA Hedge Fund Activity: Q4 2024 in Review
745 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q4 2024, worth a combined $11.5B — down 34% from $17.4B a quarter earlier.
Sellers outnumbered buyers: 170 funds closed out of MRNA and 145 opened new positions — a net loss of 25 holders — while 252 trimmed existing stakes and 232 added.
The largest buyer was Jane Street, adding an estimated $143M. The largest seller was Baillie Gifford & Co, cutting an estimated $171M.
- 745 institutional investors held Moderna (MRNA) as of Q4 2024, down from 788 in Q3 2024.
- Funds reported $11.5B of Moderna stock for Q4 2024, down 34% quarter-over-quarter.
- 145 funds opened new Moderna positions in Q4 2024 and 170 closed out, a net change of -25 holders.
- The largest Moderna buyer in Q4 2024 was Jane Street, an estimated $143M added.
- The largest Moderna seller in Q4 2024 was Baillie Gifford & Co, an estimated $171M sold.
Based on aggregated 13F filings for Q4 2024.